LJ
Lucia B. Jilaveanu

Elite Scholar


184
Works
5,148
Citations
34
H-Index
Search Authors
Author Statistics

Lucia B. Jilaveanu

Also known as: Jilaveanu, Lucia, Jilaveanu, Lucia B., L.B. Jilaveanu, Lucia B Jilaveanu, Lucia B. Jilaveanu

184

Total Works

5,148

Citations

34

H-Index

58

i10-Index

Citation & Works Trend by Year
21 years active
Top Research Topics
Cancer Immunotherapy and Biomarkers (100) Melanoma and MAPK Pathways (62) Cutaneous Melanoma Detection and Management (60) Brain Metastases and Treatment (54) Immunotherapy and Immune Responses (47)
Recent Publications
15 shown
Year Publication Title Citations Action
2026 Development of [111In]In-CHX-A″-DTPA-αCD68 for ImmunoSPECT to Image Murine Macrophages Molecular Pharmaceutics 1
2026 CD40 agonism in renal cell carcinoma enhances immune checkpoint activity through myeloid cells iScience 0
2025 1266 Spatial profiling of melanoma brain metastases exhibit elevated neural cell adhesion molecule 1 (NCAM1) protein expression and associations with immune microenvironment and treatment response Regular and Young Investigator Award Abstracts 0
2025 870 Characterization of GDF-15 expression patterns in renal cell carcinoma Regular and Young Investigator Award Abstracts 0
2025 Improving immunotherapy responses by dual inhibition of macrophage migration inhibitory factor and PD-1 JCI Insight 9
2025 Phase II Trial of Pembrolizumab in Combination With Bevacizumab for Untreated Melanoma Brain Metastases Journal of Clinical Oncology 12
2024 Decoy-resistant IL-18 reshapes the tumor microenvironment and enhances rejection by anti–CTLA-4 in renal cell carcinoma JCI Insight 17
2024 MetFinder : A Tool for Automated Quantitation of Metastatic Burden in Histological Sections From Preclinical Models Pigment Cell & Melanoma Research 2
2024 TIGIT expression in renal cell carcinoma infiltrating T cells is variable and inversely correlated with PD-1 and LAG3 Cancer Immunology Immunotherapy 4
2024 GP100 expression is variable in intensity in melanoma Cancer Immunology Immunotherapy 12
2024 Vascular mimicry as a facilitator of melanoma brain metastasis Cellular and Molecular Life Sciences 15
2024 Melanocortin-1 Receptor Expression as a Marker of Progression in Melanoma JCO Precision Oncology 15
2023 A bedside to bench study of anti-PD-1, anti-CD40, and anti-CSF1R indicates that more is not necessarily better Molecular Cancer 17
2023 1070 ‘Decoy-resistant’ IL-18 in combination with CTLA-4 blockade enhances anti-tumor efficacy in preclinical models of renal cell carcinoma Regular and Young Investigator Award Abstracts 1
2023 830 Inhibition of macrophage migration inhibitory factor (MIF) to overcome immune checkpoint resistance in melanoma Regular and Young Investigator Award Abstracts 1

Data source: OpenAlex API